The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...

Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...

Eli LillyDemand for weight-loss drugs in India has shot up.And rivals Novo Nordisk and Eli Lilly are battling for market ...

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...

The demand for weight-loss medications is rapidly increasing in India, with competitors Eli Lilly and Novo Nordisk vying for ...

Pharmarack Technologies a market leader in pharmaceutical digital supply chain and Indian pharmaceutical market intelligence, in collaboration with the Indian Pharmaceutical Alliance (IP Alliance), ...

Citing data from India-based market analysis firm Pharmarack Technologies, the publication said Lilly (NYSE:LLY) recorded ₹126M ($1.5M) worth of Mounjaro sales last month.

Citing data from India-based market analysis firm Pharmarack Technologies, the publication said Lilly (NYSE:LLY) recorded ₹126M ($1.5M) worth of Mounjaro sales last month.

Eli Lilly & Co. increased sales of weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second full month of being on offer in the South Asian country, which has the world ...

By Rishika Sadam HYDERABAD (Reuters) -Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly ...